PharmiWeb.com - Global Pharma News & Resources
08-Jul-2019

Women’s Health Diagnostics Market is Heading Up 77.2 Bn US$ By 2026

The Global Womenrsquo;s Health Diagnostics Market Size is expected to reach USD 77.2 Billion by 2026 and growing CAGR around 7.3 % during the forecast period from 2018 to 2026.

Rising adoption of point of-care diagnostics and developing occurrence of different chronic and lifestyle diseases are among the key components invigorating the development of the market. Other than this, presenting different mindfulness programs is likewise foreseen to work in support the market amid the conjecture time frame. For example, in 2014, the European Commission propelled joint activity for European Guide on Quality Improvement in Comprehensive Cancer Control.

Ladies' wellbeing diagnostics is seeing high development because of expanded subsidizing from different associations. For example, in May 2015, Abcodia got subsidizing of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to dispatch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early recognition of ovarian malignant growth.

Based on end use, the market has been bifurcated into hospital amp; diagnostics centres and home. Hospitals and diagnostic centres captures the largest market share due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is probably going to observe noteworthy development over the coming years. The development of the market can be credited to expanding interests in social insurance, developing focal point of universal gadget makers on fortifying their appropriation arranges inside the area, and epidemiological move from irresistible ailments to constant sicknesses inside provincial limits.

Free Download Sample Report Pages For Better understanding at https://www.acumenresearchandconsulting.com/request-sample/1031

The global womenrsquo;s health diagnostics market is segmented into end-user, application, and region. On the basis of end-user, the global womenrsquo;s health diagnostics market is segmented into Hospital amp; Diagnostics Centres and Home. On the basis of application, the global womenrsquo;s health diagnostics market is segmented into Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, and Prenatal Testing. The cancer segment is further bifurcated into breast cancer testing, cervical cancer testing and ovarian cancer testing. On the basis of region the global Womenrsquo;s health diagnostics market is bifurcated into Europe, Latin America, North America, Middle East amp; Africa, and Asia Pacific.

North America was at the cutting edge of the worldwide market, with an offer of somewhat over 40.0% in 2017. This can be ascribed to high selection of mechanically propelled products, product dispatches, and government activities. For instance, in September 2017, Philips propelled new ultrasound imaginative products, Philips EPIQ 7, EPIQ 5, and Affiniti 70 ultrasound frameworks, to guarantee simpler, prior, and progressively solid conclusion. This dispatch is probably going to help extend its a dependable balance in this locale. In the U.S., Home Access Health presented a home testing unit, which can be utilized to acquire an example and send it to a research facility for testing for quick and powerful determination.

Asia Pacific is anticipated to be the quickest developing district amid the estimate time frame. Healthcare infrastructure, rising mindfulness about ladies' health disorders, government activities, and expanded investment of ladies in workforce are a portion of the elements ready to decidedly impact the development of the provincial market.

In November 2016, the Indian government propelled Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) plan to give free wellbeing checkups to pregnant ladies. Under this plan, ladies would be tried for iron deficiency, high glucose (gestational diabetes), pulse, hormonal clutters, and approach free ultrasounds to follow wellbeing and advancement of child in the womb.

Brazil and Mexico are critical markets in Latin America, with the previous being the main income patron in the locale. Declining maternal death rate, expanding future, maturing ladies populace, and developing predominance of irresistible and endless illnesses are essential development stimulants for the provincial market. In 2015, Brazil began circulating self-testing packs to overall public. These packs were gotten complimentary from drug dissemination focuses, drug stores, government wellbeing programs, health services, and through sends.

The key players catering to the global Womenrsquo;s health diagnostics market are Abbott, and BD, Siemens Healthcare Private Limited, Koninklijke Philips N.V., GE Healthcare, Hologic, Inc., F. Hoffmann-La Roche Ltd. and bioMeacute;rieux SA.

View Detail Information With Complete TOC@https://www.acumenresearchandconsulting.com/womens-health-diagnostics-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Womenrsquo;s health diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Womenrsquo;s health diagnostics Market By Application
1.2.2.1. Global Womenrsquo;s health diagnostics Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.2.2. Global Womenrsquo;s health diagnostics Market Revenue Share By Application in 2017
1.2.2.3. Cancer
1.2.2.4. Infectious Disease Testing
1.2.2.5. Osteoporosis Testing
1.2.2.6. Pregnancy and Fertility Testing
1.2.2.7. Prenatal Testing
1.2.2.8. Others
1.2.3. Womenrsquo;s health diagnostics Market By End-user
1.2.3.1. Global Womenrsquo;s health diagnostics Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.3.2. Global Womenrsquo;s health diagnostics Market Revenue Share By End-user in 2017
1.2.3.3. Hospital and Diagnostics Centers
1.2.3.4. Home
1.2.3.5. Others
1.2.4. Womenrsquo;s health diagnostics Market by Geography
1.2.4.1. Global Womenrsquo;s health diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Womenrsquo;s health diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Womenrsquo;s health diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Womenrsquo;s health diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Womenrsquo;s health diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Womenrsquo;s health diagnostics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Womenrsquo;s health diagnostics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Womenrsquo;s health diagnostics Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Womenrsquo;s health diagnostics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Womenrsquo;s health diagnostics Major Manufacturers in 2017

CHAPTER 4. WOMENrsquo;S HEALTH DIAGNOSTICS MARKET BY APPLICATION

4.1. Global Womenrsquo;s health diagnostics Revenue By Application
4.2. Cancer
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Infectious Disease Testing
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Osteoporosis Testing
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Pregnancy and Fertility Testing
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Prenatal Testing
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. WOMENrsquo;S HEALTH DIAGNOSTICS MARKET BY END-USER

5.1. Global Womenrsquo;s health diagnostics Revenue By End-user
5.2. Hospital and Diagnostics Centers
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Home
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA WOMENrsquo;S HEALTH DIAGNOSTICS MARKET BY COUNTRY

6.1. North America Womenrsquo;s health diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Womenrsquo;s health diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Womenrsquo;s health diagnostics Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE WOMENrsquo;S HEALTH DIAGNOSTICS MARKET BY COUNTRY

7.1. Europe Womenrsquo;s health diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Womenrsquo;s health diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC WOMENrsquo;S HEALTH DIAGNOSTICS MARKET BY COUNTRY

8.1. Asia-Pacific Womenrsquo;s health diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Womenrsquo;s health diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA WOMENrsquo;S HEALTH DIAGNOSTICS MARKET BY COUNTRY

9.1. Latin America Womenrsquo;s health diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Womenrsquo;s health diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST WOMENrsquo;S HEALTH DIAGNOSTICS MARKET BY COUNTRY

10.1. Middle East Womenrsquo;s health diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Womenrsquo;s health diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA WOMENrsquo;S HEALTH DIAGNOSTICS MARKET BY COUNTRY

11.1. Africa Womenrsquo;s health diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Womenrsquo;s health diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Abbott
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. BD
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Siemens Healthcare Private Limited
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Koninklijke Philips N.V.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. GE Healthcare
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Hologic, Inc.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. F. Hoffmann-La Roche Ltd.
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. bioMeacute;rieux SA.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Others
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

INQUIRY BEFORE BUYING at https://www.acumenresearchandconsulting.com/inquiry-before-buying/1031

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report at https://www.acumenresearchandconsulting.com/buy-now/0/1031

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 08-Jul-2019